Non-Current Liabilities
Debt - Unamortized Discount (Premium) and Issuance Costs, Net
Amgen Debt - Unamortized Discount (Premium) and Issuance Costs, Net increased by 1.8% to $1.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.2%, from $1.35B to $1.33B. Over 5 years (FY 2020 to FY 2025), Debt - Unamortized Discount (Premium) and Issuance Costs, Net shows relatively stable performance with a 1.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ4 2015
Last reportedQ1 2026Apr 30, 2026
Metric ID:
debt_unamortized_discount_premium_issuance_costsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.17B | $1.22B | $1.21B | $1.25B | $1.25B | $1.25B | $1.25B | $1.43B | $1.44B | $1.42B | $1.42B | $1.40B | $1.39B | $1.37B | $1.36B | $1.35B | $1.33B | $1.32B | $1.31B | $1.33B |
| QoQ Change | — | +4.0% | -0.7% | +3.3% | -0.6% | +0.6% | -0.5% | +15.1% | +0.3% | -1.0% | -0.2% | -1.1% | -1.1% | -1.2% | -0.9% | -1.1% | -1.0% | -1.1% | -0.8% | +1.8% |
| YoY Change | — | — | — | — | +6.0% | +2.5% | +2.7% | +14.4% | +15.5% | +13.7% | +14.0% | -2.1% | -3.4% | -3.5% | -4.2% | -4.2% | -4.2% | -4.1% | -4.0% | -1.2% |
Range$1.17B – $1.44B
CAGR+2.6%
Avg YoY Growth+2.4%
Median YoY Growth-1.6%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net at Other Companies
Frequently Asked Questions
- What is Amgen's debt - unamortized discount (premium) and issuance costs, net?
- Amgen (AMGN) reported debt - unamortized discount (premium) and issuance costs, net of $1.33B in Q1 2026.
- How has Amgen's debt - unamortized discount (premium) and issuance costs, net changed year-over-year?
- Amgen's debt - unamortized discount (premium) and issuance costs, net decreased by 1.2% year-over-year, from $1.35B to $1.33B.
- What is the long-term trend for Amgen's debt - unamortized discount (premium) and issuance costs, net?
- Over 5 years (2020 to 2025), Amgen's debt - unamortized discount (premium) and issuance costs, net has grown at a 1.9% compound annual growth rate (CAGR), from $1.19B to $1.31B.